Published in J Cereb Blood Flow Metab on April 15, 2009
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
Imaging recommendations for acute stroke and transient ischemic attack patients: A joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery. AJNR Am J Neuroradiol (2013) 1.71
Imaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review. Expert Rev Cardiovasc Ther (2011) 1.14
Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab (2010) 1.08
Collateral perfusion: time for novel paradigms in cerebral ischemia. Int J Stroke (2012) 0.98
Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Int J Stroke (2013) 0.95
Multimodal MRI for ischemic stroke: from acute therapy to preventive strategies. J Clin Neurol (2009) 0.89
Magnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An update. World J Radiol (2012) 0.87
Reversing stroke in the 2010s: lessons from Desmoteplase In Acute ischemic Stroke-2 (DIAS-2). Stroke (2009) 0.80
Lesion development and reperfusion benefit in relation to vascular occlusion patterns after embolic stroke in rats. J Cereb Blood Flow Metab (2013) 0.80
The determinants of stroke phenotypes were different from the predictors (CHADS2 and CHA2DS2-VASc) of stroke in patients with atrial fibrillation: a comprehensive approach. BMC Neurol (2011) 0.78
Comparisons of outcomes in stroke subtypes after intravenous thrombolysis. Springerplus (2016) 0.77
Magnetic Resonance Perfusion Imaging Provides a Significant Tool for the Identification of Cardioembolic Stroke. Curr Neurovasc Res (2016) 0.75
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med (1995) 47.15
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37
Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol (2006) 10.51
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol (2008) 9.02
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke (2003) 7.75
High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med (1996) 6.90
Collateral circulation. Stroke (2003) 5.16
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke (2004) 4.39
Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry (2007) 3.51
An evidence-based causative classification system for acute ischemic stroke. Ann Neurol (2005) 3.09
Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke (2006) 3.03
Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke (2003) 2.87
MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol (2006) 2.42
Intracranial stenosis in Chinese patients with acute stroke. Neurology (1998) 2.15
Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke (2004) 2.06
Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes. Arch Neurol (2003) 1.77
Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol (2002) 1.64
Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging. Curr Opin Neurol (2005) 1.25
The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke (2008) 1.18
Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors? Arch Neurol (1990) 1.12
Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: preliminary experience. Stroke (1996) 1.10
Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. Eur J Neurol (2005) 1.06
Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. Arch Neurol (2005) 0.92
Racial differences in cerebrovascular disease. Angiographic evaluation of Japanese and American populations. Am J Roentgenol Radium Ther Nucl Med (1967) 0.91
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke (2008) 8.45
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet (2012) 7.89
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med (2002) 3.18
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18
Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science (2004) 3.01
Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke (2003) 2.87
Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke. Stroke (2006) 2.63
A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells (2010) 2.50
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol (2011) 2.46
Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation. Proc Natl Acad Sci U S A (2007) 2.43
Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke (2007) 2.36
Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler (2011) 2.30
Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke. J Stroke (2013) 2.19
Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol (2015) 2.16
VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor. Radiology (2004) 2.14
Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol (2010) 2.11
Newly suggested surgical method of decompressive craniectomy for patients with middle cerebral artery infarction. Neurologist (2011) 2.10
Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke (2003) 2.06
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03
Persistent metabolic crisis as measured by elevated cerebral microdialysis lactate-pyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury. Crit Care Med (2008) 2.00
Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke. Stroke (2013) 1.94
Diffusion tensor imaging demonstrates brainstem and cerebellar abnormalities in congenital central hypoventilation syndrome. Pediatr Res (2008) 1.86
Internal and cortical border-zone infarction: clinical and diffusion-weighted imaging features. Stroke (2006) 1.76
Longitudinal changes of resting-state functional connectivity during motor recovery after stroke. Stroke (2011) 1.75
Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis (2009) 1.71
Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol (2008) 1.71
Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke (2002) 1.68
Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke (2006) 1.59
Ramsay Hunt syndrome complicated by a brainstem lesion. J Clin Virol (2007) 1.59
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial. Int J Stroke (2012) 1.55
Neovascularization precedes occlusion in moyamoya disease: angiographic findings in 172 pediatric patients. Eur Neurol (2014) 1.54
Body mass index and hospital discharge outcomes after ischemic stroke. Arch Neurol (2007) 1.54
Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol (2007) 1.53
Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke (2010) 1.53
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla. Magn Reson Med (2007) 1.53
Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke (2003) 1.51
Early distribution of intravenously injected mesenchymal stem cells in rats with acute brain trauma evaluated by (99m)Tc-HMPAO labeling. Nucl Med Biol (2011) 1.51
Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells. Nitric Oxide (2010) 1.50
Improved outcome after atherosclerotic stroke in male smoker. J Neurol Sci (2007) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia (2009) 1.47
Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology (2014) 1.46
Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke (2007) 1.45
Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke. Stroke (2012) 1.43
Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts. Stroke (2010) 1.41
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke (2012) 1.40
Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke (2007) 1.40
Time-dependent effect of transcranial direct current stimulation on the enhancement of working memory. Neuroreport (2008) 1.39
Digitally tunable physicochemical coding of material composition and topography in continuous microfibres. Nat Mater (2011) 1.38
Peripheral calcification in thyroid nodules: ultrasonographic features and prediction of malignancy. J Ultrasound Med (2007) 1.37
Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke. Cerebrovasc Dis (2008) 1.37
A computerized in-hospital alert system for thrombolysis in acute stroke. Stroke (2010) 1.35
Neural alterations and depressive symptoms in obstructive sleep apnea patients. Sleep (2008) 1.34
Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions. AJNR Am J Neuroradiol (2003) 1.33
Reduced white matter integrity in attention-deficit hyperactivity disorder. Neuroreport (2008) 1.31
Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med (2015) 1.29
Brain responses associated with the Valsalva maneuver revealed by functional magnetic resonance imaging. J Neurophysiol (2002) 1.28
Early nonischemic oxidative metabolic dysfunction leads to chronic brain atrophy in traumatic brain injury. J Cereb Blood Flow Metab (2009) 1.28
fMRI responses to cold pressor challenges in control and obstructive sleep apnea subjects. J Appl Physiol (1985) (2003) 1.27
Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy. Stroke (2013) 1.27
Metabolite essentiality elucidates robustness of Escherichia coli metabolism. Proc Natl Acad Sci U S A (2007) 1.26